HT
GOSS icon

HAP Trading’s Gossamer Bio GOSS Stock Holding History

HAP Trading’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-16,400
Closed -$2K – 1392
2022
Q4 		$2K Buy
+16,400
New +$135K ﹤0.01% 1347
2022
Q3 		– Sell
-11,300
Closed -$9K – 1852
2022
Q2 		$9K Buy
+11,300
New +$87.6K ﹤0.01% 1500
2022
Q1 		– Sell
-11,000
Closed -$7K – 2451
2021
Q4 		$7K Buy
+11,000
New +$131K ﹤0.01% 2146

Other funds holding GOSS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

HAP Trading's GOSS Position: Q4 2019 in Review

HAP Trading sold out of Gossamer Bio (GOSS) in Q4 2019, closing a stake of 21,708 shares — an estimated $364K sold.

HAP Trading first reported a position in GOSS in Q3 2019 and held it in 1 quarter. The position peaked at $364K in Q3 2019. 88 funds tracked by Wall St. Rank hold GOSS as of Q4 2019.

  • HAP Trading reported no remaining Gossamer Bio position as of Q4 2019 after selling out during the quarter.
  • HAP Trading sold 21,708 Gossamer Bio shares in Q4 2019, an estimated $364K.
  • HAP Trading first reported a position in Gossamer Bio in Q3 2019 and held it in 1 quarter.
  • HAP Trading's Gossamer Bio position peaked at $364K in Q3 2019.
  • 88 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2019.

Based on HAP Trading's 13F filing for Q4 2019, filed 11 Feb 2020.